comparemela.com
Home
Live Updates
FDA Approves Aripiprazole as First Once-Every-2-Months Long-
FDA Approves Aripiprazole as First Once-Every-2-Months Long-
FDA Approves Aripiprazole as First Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder
The formulation in 960 mg and 720 mg prefilled syringes delivers sustained plasma concentrations comparable to those demonstrated in studies with Abilify Maintena.
Related Keywords
Abilify Asimtufii ,
Abilify Maintena ,
Johan Luthman ,
Lundbeck ,
Olivier Le Moal ,